Current Advance in Targeted Treatment and Immunotherapy for BRAF-mutant Advanced Non-small Cell Lung Cancer
With the development of precision medicine, therapies of targeting driver genes have significantly prolonged survival in advanced non-small cell lung cancer (NSCLC) patients. Among them, BRAF gene mutation is relatively rare, and the traditional regimen follows the treatment plan of NSCLC without dr...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Chinês |
| Опубліковано: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-10-01
|
| Серія: | Chinese Journal of Lung Cancer |
| Предмети: | |
| Онлайн доступ: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.29 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|